Cargando…
Concise review: programming human pluripotent stem cells into blood
Blood disorders are treated with cell therapies including haematopoietic stem cell (HSC) transplantation as well as platelet and red blood cell transfusions. However the source of cells is entirely dependent on donors, procedures are susceptible to transfusion‐transmitted infections and serious comp...
Autores principales: | Easterbrook, Jennifer, Fidanza, Antonella, Forrester, Lesley M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914896/ https://www.ncbi.nlm.nih.gov/pubmed/26996518 http://dx.doi.org/10.1111/bjh.14010 |
Ejemplares similares
-
Progress in the production of haematopoietic stem and progenitor cells from human pluripotent stem cells
por: Fidanza, Antonella, et al.
Publicado: (2021) -
Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells
por: Yang, Cheng‐Tao, et al.
Publicado: (2017) -
Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases
por: Adegbola, Abidemi, et al.
Publicado: (2017) -
Modelling the erythroblastic island niche of dyserythropoietic anaemia type IV patients using induced pluripotent stem cells
por: May, Alisha, et al.
Publicado: (2023) -
Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells
por: Petazzi, Paolo, et al.
Publicado: (2020)